Malignant melanoma and lymphoproliferative malignancy: is there a shared aetiology?

Authors: Mckenna, D.B.1; Doherty, V.R.1; Mclaren, K.M.2; Hunter, J.A.A.1

Source: British Journal of Dermatology, Volume 143, Number 1, July 2000 , pp. 171-173(3)

Publisher: Wiley-Blackwell

Buy & download fulltext article:


Price: $48.00 plus tax (Refund Policy)


We report seven patients who developed malignant melanoma either coincident with or before the diagnosis of non-Hodgkin’s lymphoma or chronic lymphatic leukaemia. One patient died secondary to leukaemia, and chemotherapy-induced immunosuppression may have contributed to the development of metastatic melanoma in another patient. Immunosuppression, exposure to ultraviolet radiation and genetic factors may result in a host environment that is conducive to the development of both tumours in these patients.

Keywords: chronic lymphatic leukaemia; immunosuppression; malignant melanoma; non-Hodgkin’s lymphoma; p16 gene; ultraviolet radiation

Document Type: Research Article


Affiliations: 1: Departments of Dermatology and 2: Histopathology, Royal Infirmary of Edinburgh, Lauriston Building, Edinburgh EH3 9YW, U.K.

Publication date: July 1, 2000

Related content



Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page